Resistance of pelvic arteries and plasma lipids in postmenopausal women: Comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 183 (3) , 575-582
- https://doi.org/10.1067/mob.2000.106769
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Fortnightly review: Hormone replacement therapyBMJ, 1998
- The effect of tamoxifen and transdermal 17β-estradiol on cerebral arterial vessels: A randomized controlled studyAmerican Journal of Obstetrics and Gynecology, 1998
- A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler studyMaturitas, 1997
- Uterine perfusion and endometrial thickness in postmenopausal. women on long‐term continuous combined estrogen and progestogen replacementUltrasound in Obstetrics & Gynecology, 1997
- Long-term Effects of Postmenopausal Hormone Replacement Therapy on Pulsatility Index of Internal Carotid and Middle Cerebral ArteriesMenopause, 1997
- Hormonal status affects the reactivity of the cerebral vasculatureAmerican Journal of Obstetrics and Gynecology, 1995
- Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal womenFertility and Sterility, 1992
- Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.Journal of Clinical Investigation, 1991
- Oestrogens, arterial status, and postmenopausal womenThe Lancet, 1990